These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22429564)

  • 1. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.
    Tarbet EB; Maekawa M; Furuta Y; Babu YS; Morrey JD; Smee DF
    Antiviral Res; 2012 Apr; 94(1):103-10. PubMed ID: 22429564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
    Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.
    Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Jang SI; Kim H; Cheong HJ; Song JW; Song KJ; Baek LJ; Park MS
    PLoS One; 2014; 9(7):e101325. PubMed ID: 24992479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.
    Tarbet EB; Vollmer AH; Hurst BL; Barnard DL; Furuta Y; Smee DF
    Arch Virol; 2014 Jun; 159(6):1279-91. PubMed ID: 24311151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.
    Abed Y; Pizzorno A; Boivin G
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4375-80. PubMed ID: 22664977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.
    Louie JK; Yang S; Yen C; Acosta M; Schechter R; Uyeki TM
    PLoS One; 2012; 7(6):e40261. PubMed ID: 22768265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.
    Li Z; Li R; Li J; Xie H; Hao Y; Du Q; Chen T; Li Y; Chen R; Yang Z; Zhong N
    BMC Infect Dis; 2016 Jul; 16():325. PubMed ID: 27392915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.
    Sugaya N; Kohno S; Ishibashi T; Wajima T; Takahashi T
    Antimicrob Agents Chemother; 2012 Jan; 56(1):369-77. PubMed ID: 22024821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.
    Boltz DA; Ilyushina NA; Arnold CS; Babu YS; Webster RG; Govorkova EA
    Antiviral Res; 2008 Nov; 80(2):150-7. PubMed ID: 18573280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation.
    Abed Y; Simon P; Boivin G
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2819-22. PubMed ID: 20404128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
    Hernandez JE; Adiga R; Armstrong R; Bazan J; Bonilla H; Bradley J; Dretler R; Ison MG; Mangino JE; Maroushek S; Shetty AK; Wald A; Ziebold C; Elder J; Hollister AS; Sheridan W;
    Clin Infect Dis; 2011 Mar; 52(6):695-706. PubMed ID: 21367722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
    Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
    Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
    Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Kuwahara T; Shimazu Y; Shimomura T; Watanabe S; Odagiri T;
    Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir.
    Campbell AP; Jacob ST; Kuypers J; Wald A; Englund JA; Corey L; Boeckh M
    Ann Intern Med; 2010 May; 152(9):619-20. PubMed ID: 20439588
    [No Abstract]   [Full Text] [Related]  

  • 17. Peramivir for the treatment of influenza.
    Shetty AK; Peek LA
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
    Baz M; Carbonneau J; Rhéaume C; Cavanagh MH; Boivin G
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients.
    Kohno S; Kida H; Mizuguchi M; Hirotsu N; Ishida T; Kadota J; Shimada J;
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2803-12. PubMed ID: 21464252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice.
    Smee DF; Hurst BL; Wong MH; Bailey KW; Tarbet EB; Morrey JD; Furuta Y
    Antimicrob Agents Chemother; 2010 Jan; 54(1):126-33. PubMed ID: 19901093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.